EUDA Health Limited (EUDA)
NasdaqCM: EUDA
· Real-Time Price · USD
14.17
+0.00 (0.00%)
At close: Aug 14, 2026, 2:50 PM
EUDA Health Limited (EUDA) Stock Price, Analysis & Data
0.00% (1D)
| Bid | 9.47 |
| Market Cap | 42.52M |
| Revenue (ttm) | 6.82M |
| Net Income (ttm) | -2.77M |
| Beta | 0.64 |
| EPS (ttm) | -1.48 |
| PE Ratio (ttm) | n/a |
| Forward PE | 8.88 |
| P/B (ttm) | -6.31 |
| P/S (ttm) | 6.23 |
| Earnings Date | n/a |
| Ask | 18.27 |
| Volume | 36 |
| Avg. Volume (20D) | 5,167 |
| Open | 14.49 |
| Previous Close | 14.17 |
| Day's Range | 14.17 - 14.17 |
| 52-Week Range | 5.26 - 86.00 |
| Analyst | n/a |
| Price Target | 55 (288.14%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About EUDA
EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services. The company also provides property management services. The company was founded in 2019 and is headquartered in Singapore....
Industry Real Estate Services
Sector Real Estate
IPO Date Dec 14, 2021
Employees 123
Stock Exchange NasdaqCM
Ticker Symbol EUDA
Website https://eudahealth.com
Financial Performance
In 2025, EUDA Health's revenue was 6.82M, an increase of 70.04% compared to the previous year's 4.01M. Earnings were -2.77M, a decrease of -81.94%.
Financial StatementsAnalyst Forecast
According to 1 analyst ratings, the average rating for EUDA stock is "null". The 12-month stock price forecast is 55, which is upside of 288.14% from the latest price.
Stock Forecasts